Glowing Plant Is One of Y Combinator’s First Biotech Startups
techcrunch.com
techcrunch.com
(I work with human genetics and am fascinated by the prevalence of structural variation.)
So, surface of sphere is proportional to r2. At distance r, with 1/r absorption, the illumination of a spot on a sphere at distance r would fall off as 1/r3. But I wasn't including absorption, so my original claim of 1/r3 due to spherical emission was wrong.
Note: Sugarcane peaks at around 7-8% efficient so with the right plant .25w seems doable.
You said elsewhere that you're increasing brightness 10-25% per week, which seems crazy fast. How fast do your plants reach maturity?
edit: If I got these I'd be breeding it with all sorts of other close species; see what sticks.
This plant is wasting energy by glowing. It serves no purpose that enhances the plant's fitness outside of a human environment. If it were released into the wild, chances are it would lose out in natural selection vs wild competitors.
The same is true of most human domesticated species, most of which are effectively genetically engineered through ages of selective breeding. Picture dogs vs wolves, cows vs wild buffalo, etc.
Seriously? As the CEO of the company and the person ultimately responsible for this project, it is troubling that you endorse these simplistic and erroneous views of plant biosafety. Fitness is notoriously ecosystem-dependent and hard to predict, which is why microcosm and field experiments-based risk assessments exist in the first place --it unfortunately can't just be eyeballed from a simple metabolic account like that. And either way there is the additional risk of transgene flow, which is even more long-term and less understood --especially for such relatively distant horizontal transfers.
You might have (unaccountably) skirted APHIS regulation, but that doesn't mean you don't have an ethical obligation to (1) thoroughly assess the biosafety of these plants; and (2) be frank in communicating these risks (and their uncertainty) to the public, even if they do not make as clean of a narrative as one would like.
Also, specifically to your point about transgene flow. Higher level organisms (eg animals, plants) very very rarely exchange DNA - this is a good thing or else you might start photosynthesizing after eating salad for lunch. There are a couple of recent papers saying maybe (and that's maybe in a scientific probability, ie small probability) this happens on the order of millions of years. APHIS doesn't even look at this issue anymore, here's their comment on it:
Potential impacts from transferring genetic information from plant to organisms with which it cannot interbreed • First, many genomes (or parts thereof) have been sequenced from bacteria that are closely associated with plants including Agrobacterium and Rhizobium (Kaneko et al. 2000; Wood et al. 2001; Kaneko et al. 2002). There is no evidence that these organisms contain genes derived from plants. • Second, in cases where review of sequence data implied that horizontal gene transfer occurred, these events are believed to occur on an evolutionary time scale on the order of millions of years (Koonin et al. 2001; Brown 2003). • Third, transgene DNA promoters and coding sequences are optimized for plant expression, not prokaryotic bacterial expression. Thus even if horizontal gene transfer occurred, proteins corresponding to the transgenes are not likely to be produced. • Fourth, the FDA has evaluated horizontal gene transfer from the use of antibiotic resistance marker genes, and concluded that the likelihood of transfer of antibiotic resistance genes from plant genomes to microorganisms in the gastrointestinal tract of humans or animals, or in the environment, is remote (Council for Biotechnology Information, 2001; http://vm.cfsan.fda.gov/~dms/opa-armg.html, accessed 1/26/10). • Finally, a recent review of issues related to horizontal gene transfer concluded that this type of gene transfer is unlikely to occur and poses negligible risks to human health or the environment (Keese 2008).
Far from it! The very workshop minutes you are citing [1, Appendix 3] directly contradict your point, with participants raising a number of serious concerns about your project:
"Many questions focused on the ethical and philosophical issues associated with the project, including matters of consenting public and responsible science practice. However, only questions relating to the research agenda, like those impacting regulatory consideration and potential ecological effects, are included here.
Ecological interactions:
- How will the impact of the bioluminescence from the plants on wild organisms be tracked across seed destinations? If this can’t be tracked or known ahead of time, then how is the application ready for release?
- How have the interactions of insects with the glowing plant been characterized? Does this have the potential to disrupt pollinators?
- Arabadopsis is frequently used in laboratories specifically because it is easy to grow and is a weedy species. How does this align with comments made regarding the difficulty of growing the plants, and the extreme unlikelihood that the seeds would take root and grow if released outdoors?
- Were any types of biocontrol mechanisms employed or tested in the system? Why was sterility not introduced into the system when it could serve such a purpose?
Determining regulatory coverage:
- Habitats of relevance.
- Tests for characterizing the application: The seed packets will not be regulated because the seeds were created using gene guns, while the DIY maker kits will be regulated because the system will rely on Agrobacterium. Neither can be shipped internationally. However, once these are distributed, how will use be monitored? If the plants are expected to be sent to thousands of individual sites around the country, how are habitats of relevance being determined? Are all of these locations being tracked, characterized, and assessed for specific vulnerabilities in advance of product release? The USDA APHIS test framework is insufficient for this purpose. How could a model be developed to evaluate such a widely distributed application? What questions would need addressing in order to appropriately characterize the effort?
- Demonstration of impact: Compare the altered plants to other mustards, and assess how well they grow. A series of greenhouse competition assays in a variety of environ- ments would be a good start, and any identified differences could point to areas requiring further study. Also study known pathway interactions up- and downstream. Emphasize the study of the resulting phenotypes, not the genetic modifications."
[1] http://www.wilsoncenter.org/sites/default/files/SYNBIO_res_a...
First, what you cite is not a comment from APHIS, but a verbatim quote from an earlier post from your company blog [1]; which is supposed to be a draft outline of proposed biosafety tests, but which largely consists of paraphrases and language from two already completed APHIS plant pest risk assessments for a completely unrelated rose variety using plasmid transgenes, some of whose conclusions and comments you then use to (wrongly) extrapolate about your product and its risks. This is highly misleading, to say the least.
Second, your statements about transgene flow risk are outdated and mischaracterize current knowledge. Suffice to say, your technical team (or even any of the experts you engage with, say, in SYNBIO 7) is more than capable of briefing you on the current re-assessment and state of the art.
Best of luck with your project, but do keep in mind ethical obligations to your stakeholders override any other imperatives or agendas you might have.
[1] http://blog.glowingplant.com/post/57840496382/tests-we-plan-...
Don't be silly. It's only in movies that monsterous mutations appear.
What consequences could this kind of useless, extra metabolical burden (luminescence) have? It would quickly disappear in nature.
I've since done quite a bit of research on it, and there are some pretty serious obstacles. I assume you want to use luciferase... are you going to insert the whole enzymatic pathway? or sell "glowing plant fuel"? How do you get around the fact that this uses quite a bit of the plant's energy? Are you planning on attaching promoters that hack into the plant's day/night cycle? or seasonal changes?
http://en.wikipedia.org/wiki/List_of_bioluminescent_fungi
They don't last as long as the plants, but if you get the right ones then you can eat them once you're done.
Will the plants produce seeds? Reproduce? Will the glow genes reappears in successive generations?
I'd never have a glofish but I'd buy a plant in a heartbeat. I'd guess you'd sell a lot of these through retail on impulse, just like carnivorous plants - kids get dragged to the DIY superstore and walk away with a pacifying plant.
I can't wait to see what the next several decades bring in this space.